Peregrine Asset Advisers’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,120	Closed	-$287K	–	100
2017 Q1	$287K	Buy	2,120 +120	+6%	+$16.2K	0.15%	65
2016 Q4	$287K	Buy	+2,000	New	+$287K	0.17%	81